Efficacy of simvastatin in children with hyperlipidemia secondary to kidney disorders

Pediatric Nephrology

Volumn 24, Issue 6, 2009, Pages 1205-1210

  García de la Puente, Silvestre ^a   Luis Arredondo García, José ^a   Gutiérrez Castrellón, Pedro ^a   Bojorquez Ochoa, Aurora ^a   Reyna Maya, Edith ^a   Del Pilar Pérez Martínez, María ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Children; Clinical trial; Hyperlipidemia; Nephropathies; Simvastatin

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CROSSOVER PROCEDURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; HYPERLIPIDEMIA; INFECTION; LIPOPROTEIN BLOOD LEVEL; MALE; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT COURSE THERAPY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ANTILIPEMIC AGENTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; HYPERLIPIDEMIAS; KIDNEY DISEASES; PILOT PROJECTS; SIMVASTATIN; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 67650289824     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1128-7     Document Type: Article

References (21)

1. Tracy RE, Newman WP 3rd, Wattigney WA, Srinivasan SR, Strong JP, Berenson GS (1995) Histologic features of atherosclerosis and hypertension from autopsies of young individuals in a defined geographic population: The Bogalusa Heart Study. Atherosclerosis 116:163-179
2. Ross SD, Allen IE, Connelly JE, Korenblat BM, Smith ME, Bishop D, Luo D (1999) Clinical outcomes in statin treatment trials: A meta-analysis. Arch Intern Med 159:1793-1802
3. Kaysen GA (1991) Hyperlipidemia of the nephrotic syndrome. Kidney Int 39 [Suppl 31]:S8-S15
4. Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M (1990) Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323:579-584
5. Chan MK, Varghese Z, Moorhead JF (1981) Lipid abnormalities in uremia, dialysis and transplantation (review). Kidney Int 19:625-637
6. Querfeld U (1993) Disturbances of lipid metabolism in children with chronic renal failure. Pediatr Nephrol 7:749-757
7. Attman PO, Alaupovic P (1991) Lipid abnormalities in chronic renal insufficiency. Kidney Int 39 [Suppl 31]:S16-S23
8. Drueke TB, Abdulmassih Z, Lacour B, Bader C, Chevallier A, Kreis H (1991) Atherosclerosis and lipid disorders after renal transplantation. Kidney Int 39 [Suppl 31]:S24-S28
9. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long term pediatric renal transplant recipients. Pediatr Nephrol 14:105-110
10. Aguilar-Salinas CA, Díaz-Polanco A, Quintana E, Macías N, Arellano A, Ramírez E, Ordóñez ML, Velásquez-Alva C, Gómez Pérez FJ, Alberú J, Correa-Rotter R (2002) Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation. Am J Kidney Dis 40:169-177
11. Duplaga BA (1999) Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors. Ann Pharmacother 33:1224-1227
12. Avis HJ, Vissers MN, Stein EA, Wijburg FA, Trip MD, Kastelein JJ, Hutten BA (2007) A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 27:1803-1810
13. Massy ZA, Luois TA, Kasike BL (1995) Lipid-lowering therapy in patients with renal disease. Kidney Int 48:188-198
14. Vrecer M, Turk S, Drinovec J, Mrhar A (2003) Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther 41:567-577
15. Henyan NN, Riche DM, East HE, Gann PN (2007) Impact of statins on risk of stroke: A meta-analysis. Ann Pharmacother 41:1937-1945
16. Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J (2007) The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: A pooled analysis of double-blind, randomized trials. Int J Cardiol 117:64-74
17. Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJ, Hutten BA (2007) Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation 116:664-668
18. Coleman JE, Watson AR (1996) Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood. Pediatr Nephrol 10:171-174
19. Sanjad SA, Al-Abbad A, Al-Hhorafa S (1997) Management of hyperlipidemia in children with refractory nephrotic syndrome: The effect of statin therapy. J Pediatr 130:470-474
20. Edwards JE, Moore RA (2003) Statins in hypercholesterolaemia: A dose-specific meta- analysis of lipid changes in randomized, double blind trials. BMC Fam Pract 4:18
21. Law M, Rudnicka AR (2006) Statin safety: A systematic review. Am J Cardiol 97:52C-60C